Capstone Investment Advisors, LLC Geron Corp Transaction History

Capstone Investment Advisors, LLC

  • $30.4 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024
SELL
$1.74 - $2.31 $97,774 - $129,803
-56,192 Reduced 46.97%
63,437 $133,000
Q3 2023

Nov 13, 2023
BUY
$2.11 - $3.28 $223,432 - $347,325
105,892 Added 770.85%
119,629 $253,000
Q2 2023

Aug 10, 2023
BUY
$1.97 - $3.69 $27,061 - $50,689
13,737 New
13,737 $44,000
Q4 2018

Feb 14, 2019
SELL
$0.98 - $1.85 $49,000 - $92,500
-50,000 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$1.76 - $6.38 $88,000 - $319,000
50,000 New
50,000 $88,000

Others Institutions Holding GERN

# of Institutions
275
Shares Held
491M
Call Options Held
1.87M
Put Options Held
690K
View Full List

About GERON CORP

GERN Quotes by TradingView
  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.54B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email